As the drug plan landscape evolves, the nuanced tension between cost management and the imperative to support employee health continues, according to a panel of experts discussing Benefits Canada’s inaugural Drug Plan Opinion Survey during the 2025 Face to Face Drug Plan Management Forum. The survey, which polled 124 Canadian plan sponsors with at least […]
As Canada navigates the evolving drug coverage landscape, private drug plans remain a cornerstone of access, innovation and economic growth. Indeed, private drug plans are more than just a benefit for employees; they’re a critical driver for the Canadian health-care system and the economy, according to Joe Farago, executive director of market access and interim […]
An article on changes to Newfoundland and Labrador’s employee leave legislation was the most-read benefits story on BenefitsCanada.com this year. Here are the top 10 benefits stories of 2025: 1. What Newfoundland and Labrador-based employers need to know about changes to employee leave legislation 2. How national health-care legislation could impact benefits plan sponsors’ virtual […]
While Health Canada’s approval of the first drug to specifically treat postpartum depression represents a clinical milestone in women’s mental health, one benefits expert says its impact on employer-sponsored drug plans is likely to be limited. Zuranolone, sold under the brand name Zurzuvae, is a 14-day oral treatment designed to provide rapid symptom relief for […]
An article on Ontario’s proposed changes to preferred pharmacy network agreements was the most-read story on BenefitsCanada.com this past week. Here are the top five human resources, benefits, pension and investment stories of the last week: 1. How Ontario’s proposed changes to preferred pharmacy networks could reshape drug plan costs 2. How predictability in the […]
Ontario’s signal that it may restrict or eliminate preferred pharmacy networks has created urgency for plan sponsors that rely on these arrangements to manage drug plan costs and access. Preferred pharmacy networks have been used in private drug plans for more than a decade. A PPN is a group of pharmacies selected because they offer […]
As effective weight management drugs come to market, it’s time to move beyond outdated approaches to obesity care and towards holistic treatment strategies, said Marie-Hélène Dugal, national pharmacy strategy lead for Medavie Blue Cross, during Benefits Canada’s 2025 Toronto Benefits Summit. Obesity is a progressive, relapsing and complex chronic disease characterized by abnormal and excessive […]
While roughly half of Canada’s provinces now provide some form of public coverage for fertility treatments such as in-vitro fertilization, the cost is still too prohibitive for many people. Employers are starting to help bridge the gap, “but there’s definitely still room for improvement,” said Tara Wood, principal of Purpose PR and co-founder of Fertility […]
At the Marriott Pinnacle Downtown on May 13, Benefits Canada hosted the 2025 Vancouver Benefits Summit, an event designed for B.C.-based employers, advisors and consultants. Across several insightful sessions, the event’s attendees learned about what matters most to their employees and overall workforce health, including holistic well-being programs, fertility benefits, pharmacy care, hormonal health and […]
Weight management medications emerged as the fastest growing drug category in 2024, with claims for these drugs surging by 90.6 per cent since 2023, according to Telus Health’s annual drug report. The report, which is based on claims data from more than 15 million plan members in 2024, found the increase in claims was driven […]